We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A flyer to circulate to customers alongside a field safety notice covering what it is and why it's important to take action.
Guidelines for communicating clear and relevant information about machine learning-enabled medical devices.
Information about suspected side effects of e-cigarettes and how to report side effects.
Guidance for manufacturers of cardiac implantable electronic devices and their leads. It outlines specific scenarios that should be considered when determining if an incident is reportable.
The approach the MHRA intends to take for products approved or pending in decentralised procedure (DCP) or mutual recognition procedures (MRP).
This publication supports local authority health and wellbeing boards to develop and update pharmaceutical needs assessments (PNAs).
Advice and guidance on the management and use of point-of-care testing (POCT) in vitro diagnostic (IVD) devices.
Dear colleague letter from Barry Cockcroft, Chief Dental Officer, dated 24 March 2011. Download :National Institute for Health and Clinical…
Guidance for manufacturers of coronary stents. It outlines specific scenarios that should be considered when determining if an incident is reportable.
Recommendations from the independent Expert Advisory Group to the MHRA on the use of paclitaxel balloon catheters and stents to treat peripheral arterial disease.
Information relating to parallel imports and the implementation of the Windsor Framework.
The MHRA has published advice for patients and healthcare professionals
How to apply to have nutritional or dermatological products reviewed by the Advisory Committee on Borderline Substances (ACBS).
Guidance for marketing authorisation holders on drafting direct healthcare professional communications (DHPCs)
Guidance on how Pharmacy First will help pharmacies support their communities, with information on the new clinical pathways and fee structure.
Guidance on the steps manufacturers and suppliers can take to ease supply shortages.
A taxonomy of different incident types, modalities and outcomes in clinical imaging, MRI and nuclear medicine.
Guidance and advice for community pharmacies in England providing services to people who use drugs and alcohol.
MHRA’s mechanism for evaluating the justifications supplied by applicant organisations who plan to utilise decentralised manufacture.
Information for manufacturers of software as a medical device, detailing events that may cause indirect harm and are therefore reportable.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).